The European Commission has granted Swedish researchers over 5 million euros to conduct a clinical phase III study on patients with cystic fibrosis.
Antibodies from hen's eggs (IgY) may shortly come to revolutionize the treatment of patients suffering from the incurable disease cystic fibrosis. Most patients with cystic fibrosis are affected by severe and ultimately chronic infections with Pseudomonas aeruginosa bacteria. To date, the only treatment has been repeated courses of antibiotics, with a high risk of side effects and bacterial resistance. The IgY-method, using antibodies from hen's eggs, prevents infections and is also interesting as an alternative treatment to antibiotics in the struggle against other bacteria where the trend is an increase in the resistance. Antibiotic resistance is today the single most alarming threat against common health in Europe.
Click "source" for entire article.